gabapentin NDC 62756-204

NDC codes

FDA NDC Directory

Product NDC (as listed)62756-204Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62756-0204Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62756-204-01	62756020401	100 TABLET, FILM COATED in 1 BOTTLE (62756-204-01)Marketed from Sep 1, 2022
62756-204-03	62756020403	500 TABLET, FILM COATED in 1 BOTTLE (62756-204-03)Marketed from Sep 1, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): gabapentin
Generic name (nonproprietary): gabapentin
Active ingredients: Gabapentin — 800 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Sun Pharmaceutical Industries, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077525
Marketing start: Sep 1, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 62756-204_ca2658ac-c659-4217-8625-a1043d211cd5SPL ID ca2658ac-c659-4217-8625-a1043d211cd5SPL set ID c9a05f0c-b5f0-422c-9d67-6d0efc921a74UNII 6CW7F3G59XUPC 0362756204010, 0362756202016, 0362756138025, 0362756137028, 0362756139022

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462756020401 followed by a unit qualifier and the quantity

Package 62756-0204-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 2, 2026.

Indications (excerpt from the label)

Gabapentin is indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy Gabapentin is indicated for: Postherpetic neuralgia in adults ( 1 ) Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 077525

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077525
Product	Strength	Form · route	Labeler	Product NDC
gabapentin	Gabapentin 600 mg/1	Tablet, Film coatedOral	Aphena Pharma Solutions - Tennessee, LLC	71610-069
gabapentin	Gabapentin 600 mg/1	Tablet, Film coatedOral	Sun Pharmaceutical Industries, Inc.	62756-202